(A Critical Appraisal of) Classification of Hypereosinophilic Disorders
Open Access
- 5 December 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 4, 216
- https://doi.org/10.3389/fmed.2017.00216
Abstract
Hypereosinophilia (HE) is a heterogeneous condition that can be reported in various (namely inflammatory, allergic, infectious, or neoplastic) diseases with distinct pathophysiological pathways. In 1975, Chusid et al. published the first diagnostic criteria of hypereosinophilic syndromes (HES). Over the years, as both basic and clinical knowledge improved, several updates have been suggested, with a focus on better distinguishing isolated or asymptomatic eosinophilia from diseases with specific eosinophil-related organ damage. Moreover, underlying molecular and cellular mechanisms of eosinophilia gradually became the cornerstone of successive attempts to classify HE-related diseases. In 2011, the International Cooperative Working Group on Eosinophil Disorders criteria emerged from a multidisciplinary Working Conference on Eosinophil Disorders and Syndromes, and provided substantial contribution to the clarification of general concepts and definitions in the field of HE. Yet, owing to the low prevalence of HE/HES, to the numerous diseases encompassed in the spectrum of HE-related disorders (with sometimes overlapping phenotypes), many questions are left unanswered (e.g., the need to better standardize the use of modern molecular tools, or the clinical relevance of distinguishing different subtypes of idiopathic HES). Here, we review the current state of knowledge in the fields of classification and diagnosis criteria of HE-related diseases, with emphasis on the analysis of both strengths and weaknesses of present concepts and their usefulness in daily practice.This publication has 34 references indexed in Scilit:
- Marked and persistent eosinophilia in the absence of clinical manifestationsJournal of Allergy and Clinical Immunology, 2014
- Chronic eosinophilic leukemia‐not otherwise specified has a poor prognosis with unresponsiveness to conventional treatment and high risk of acute transformationAmerican Journal of Hematology, 2012
- Natural History of Eosinophilic GastroenteritisClinical Gastroenterology and Hepatology, 2011
- Refining the definition of hypereosinophilic syndromeJournal of Allergy and Clinical Immunology, 2010
- Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyJournal of Allergy and Clinical Immunology, 2009
- Lymphocytic Variant Hypereosinophilic SyndromesImmunology and Allergy Clinics of North America, 2007
- Approaches to the treatment of hypereosinophilic syndromes: A workshop summary reportJournal of Allergy and Clinical Immunology, 2006
- A Tyrosine Kinase Created by Fusion of thePDGFRAandFIP1L1Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic SyndromeThe New England Journal of Medicine, 2003
- Clonal Proliferation of Type 2 Helper T Cells in a Man with the Hypereosinophilic SyndromeThe New England Journal of Medicine, 1994
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975